180-Day Outcomes in Critically Ill Patients with COVID-19 in the REMAP-CAP Randomized Clinical Trial
Back to course
Video Transcription
Video Summary
Asset Subtitle
Research, Infection, 2023
Asset Caption
Type: two-hour concurrent | Late-Breaking Studies Affecting Patient Outcomes (SessionID 9000007)
Meta Tag
Content Type Presentation
Knowledge Area Research
Knowledge Area Infection
Membership Level Professional
Membership Level Select
Tag Outcomes Research
Tag COVID-19
Year 2023
Keywords
Remap-Cap trial
community-acquired pneumonia
COVID-19
interleukin-6 receptor antagonists
antiplatelets